3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Recurrence
1
Pain, Postoperative
1
Neoplasms, Plasma Cell
1
Lung Neoplasms
1
Immunoglobulin Light-chain Amyloidosis
1
Glioma
1
Glioblastoma
1
Interventions
Magnetic Resonance Spectroscopy
9
Blood Specimen Collection
9
Radiotherapy
7
Surveys and Questionnaires
6
Surgical Procedures, Operative
4
vorasidenib
3
Temozolomide
3
Aminolevulinic Acid
3
X-Rays
2
Watchful Waiting
2
Polymerase Chain Reaction
2
Neuropsychological Tests
2
Mental Status and Dementia Tests
2
Magnetic Resonance Imaging
2
Fluorodeoxyglucose F18
2
Diagnostic Imaging
2
Cancer Vaccines
2
Amplified Fragment Length Polymorphism Analysis
2
vinyltriethoxysilane
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
gadoterate meglumine
1
gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate
1
fluorodopa F 18
1
fluarix
1
apatinib
1
Ultrasonography
1
Transurethral Resection of Bladder
1
Trail Making Test
1
Tetanus Toxoid
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Glioma
×
Dexamethasone
×
Clear all
NCT04128774
2024-11-26
GBMdexaB
Amsterdam UMC, location VUmc
Terminated
5 enrolled